These findings suggest the potentiality of radiation‐guided technology to enhance the reliability of PSMA PET‐guided biopsy, providing immediate confirmation of lesion presence during surgery, and could improve biopsy outcomes in prostate cancer diagnosis. The gene discussed is FOLH1; the disease is prostate cancer.